Abstract

Hereditary haemorrhagic telangeiectasia (HHT) is an autosomal dominant hereditary disease, which affects 15.6/100,000 people in Denmark. In this review, we summarize the current Danish practice on screening, diagnosis, treatment and outpatient control of HHT patients, put an emphasis on the importance of proper screening and treatment of HHT-associated anaemia, and address the latest addition of biological treatment and advances in genetic sequencing to be utilized in HHT.
Bidragets oversatte titelHereditary haemorrhagic telangeiectasia
OriginalsprogDansk
ArtikelnummerV11240781
TidsskriftUgeskrift for Læger
ISSN0041-5782
DOI
StatusE-pub ahead of print - 2. jun. 2025

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hereditær hæmoragisk telangiektasi'. Sammen danner de et unikt fingeraftryk.

Citationsformater